Polymetal International plc Logo

Polymetal International plc

A top global gold and silver producer with mining and exploration operations in Kazakhstan.

POLY | MOEX

Overview

Corporate Details

ISIN(s):
JE00B6T5S470 (+1 more)
LEI:
213800JKJ5HJWYS4GR61
Country:
Kazakhstan
Address:
OFFICE 1306, 10 DINMUKHAMED QONAYEV STREET, ESIL DISTRICT, 010000 ASTANA
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Solidcore Resources plc, formerly known as Polymetal International plc, is a precious metals mining company. The company's primary activities involve the exploration, development, and operation of a portfolio of gold and silver producing mines. Its product portfolio consists mainly of gold and silver, with some copper production. Solidcore Resources focuses on growing its production base through strategic investments in its assets and development projects. The company was a top-10 global gold and silver producer under its former name and continues to operate primarily in Kazakhstan.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 08:05
Interim Report
Half-year report for the six months ended 30 June 2025
English 1.4 MB
2025-07-31 07:51
Earnings Release
Q2 2025 production results
English 154.6 KB
2025-07-30 12:00
Post-Annual General Meeting Information
Shareholder approval of Final Exchange Offer and Mandatory Buyback of blocked s…
English 46.0 KB
2025-07-22 09:14
Capital/Financing Update
US$ 100 million credit facility from ING
English 9.7 KB
2025-07-14 08:45
Share Issue/Capital Change
Final Exchange Offer and Mandatory Buyback of blocked shares
English 56.4 KB
2025-04-29 03:48
Earnings Release
Q1 2025 production results
English 95.3 KB
2025-03-31 16:00
Earnings Release
Preliminary results for the year ended 31 December 2024
English 1.8 MB
2025-03-12 07:40
M&A Activity
Acquisition of Tokhtar gold property in Kazakhstan
English 15.3 KB
2025-03-11 07:40
M&A Activity
Acquisition of Tokhtar gold property in Kazakhstan
English 15.3 KB
2025-02-28 07:50
Capital/Financing Update
US$ 100 million credit facility from Eurasian Development Bank
English 9.4 KB
2025-02-27 07:50
Capital/Financing Update
US$ 100 million credit facility from Eurasian Development Bank
English 9.4 KB
2025-02-20 07:32
Capital/Financing Update
Company secures a US$ 60 million investment loan from BCC for green projects
English 10.4 KB
2025-02-19 07:32
Capital/Financing Update
Company secures a US$ 60 million investment loan from BCC for green projects
English 10.4 KB
2025-01-30 08:34
Earnings Release
Q4 and FY 2024 production results
English 170.7 KB
2025-01-29 08:34
Regulatory News Service
Q4 and FY 2024 production results
English 170.7 KB

Automate Your Workflow. Get a real-time feed of all Polymetal International plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Polymetal International plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Polymetal International plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.